Labindia Liteforce Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 09-07-2024
- Paid Up Capital ₹ 2.50 M
as on 09-07-2024
- Company Age 6 Year, 9 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 100.00%
(FY 2022)
- Profit 8.56%
(FY 2022)
- Ebitda 133.64%
(FY 2022)
- Net Worth -13.76%
(FY 2022)
- Total Assets -14.47%
(FY 2022)
About Labindia Liteforce
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Umesh Pawa, Varun Upadhye, and Virendra Upadhye serve as directors at the Company.
- CIN/LLPIN
U33309PN2018PTC180808
- Company No.
180808
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Dec 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Labindia Liteforce?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Virendra Upadhye | Director | 17-Dec-2018 | Current |
Umesh Pawa | Director | 22-Jun-2020 | Current |
Varun Upadhye | Director | 16-Aug-2019 | Current |
Financial Performance of Labindia Liteforce.
Labindia Liteforce Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 100% increase. The company also saw a slight improvement in profitability, with a 8.56% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Labindia Liteforce?
In 2020, Labindia Liteforce had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Lipomic Medical Private LimitedActive 11 years 4 months
Umesh Pawa and Virendra Upadhye are mutual person
- Mobikern Automotive Engineering Private LimitedActive 8 years 7 months
Varun Upadhye and Virendra Upadhye are mutual person
- Labindia Analytical Instruments Private LimitedActive 14 years 10 months
Virendra Upadhye is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Labindia Liteforce?
Unlock and access historical data on people associated with Labindia Liteforce, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Labindia Liteforce, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Labindia Liteforce's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.